论文部分内容阅读
目的探讨动静脉联合溶栓(IV+IA)治疗急性缺血性脑卒中(CIS)的临床疗效。方法选取2013年4月—2015年4月漯河医学高等专科学校第二附属医院收治的CIS患者163例,依据不同溶栓治疗方法分为A组82例与B组81例。A组患者进行静脉溶栓(IV)治疗,B组患者进行IV+IA治疗。结果 B组患者闭塞血管再通优于A组,颅内出血发生率低于A组,美国国立卫生研究院卒中量表(NIHSS)评分优于A组,并发症发生率低于A组,差异有统计学意义(P<0.05);两组患者病死率比较,差异无统计学意义(P>0.05)。结论 IV+IA治疗CIS的临床疗效显著,可改善患者神经功能,且并发症少,安全性高。
Objective To investigate the clinical efficacy of intravenous arteriovenous thrombolysis (IV + IA) in the treatment of acute ischemic stroke (CIS). Methods A total of 163 CIS patients admitted to the Second Affiliated Hospital of Luohe Medical College from April 2013 to April 2015 were divided into group A (82 cases) and group B (81 cases) according to different thrombolysis methods. Patients in group A received intravenous thrombolysis (IV) and patients in group B received IV plus IA. Results The recanalization of occlusion in group B was better than that of group A. The incidence of intracranial hemorrhage in group B was lower than that of group A. The NIHSS score was superior to that of group A and the complication rate was lower than that of group A Statistical significance (P <0.05). There was no significant difference in mortality between the two groups (P> 0.05). Conclusion The clinical efficacy of IV + IA in the treatment of CIS is significant, which can improve the neurological function of patients with less complications and high safety.